FBT
First Trust NYSE Arca Biotechnology Index Fund
1W: +2.8%
1M: +3.0%
3M: +14.4%
YTD: +34.9%
1Y: +47.5%
3Y: +103.9%
5Y: +71.5%
Error: Binder Error: Contents of view were altered: types don't match! Expected [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, VARCHAR], but found [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, BIGINT, VARCHAR] instead
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$1.7B
Holdings30
Top 10 Wt36.0%
Volume40,471
Avg Volume77,516
Beta0.76
Portfolio Fundamentals
P/E38.5
P/B6.7
Div Yield0.19%
ROE13.6%
% Profitable68%
Inception2006-06-23
Sector Allocation
Healthcare
99.8%
Other
0.1%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | Genmab A/S (ADR) | GMAB | 3.90% | $118.0M | 2,641,348 |
| 2 | Halozyme Therapeutics, Inc. | HALO | 3.77% | $113.9M | 886,748 |
| 3 | Biogen Inc. | BIIB | 3.62% | $109.6M | 433,808 |
| 4 | Veracyte, Inc. | VCYT | 3.60% | $108.8M | 2,164,820 |
| 5 | Regeneron Pharmaceuticals, Inc. | REGN | 3.54% | $107.0M | 131,158 |
| 6 | Exelixis, Inc. | EXEL | 3.53% | $106.9M | 1,635,729 |
| 7 | Alkermes Plc | ALKS | 3.53% | $106.9M | 2,411,100 |
| 8 | Amgen Inc. | AMGN | 3.50% | $105.7M | 236,013 |
| 9 | ADMA Biologics, Inc. | ADMA | 3.49% | $105.6M | 9,451,234 |
| 10 | United Therapeutics Corporation | UTHR | 3.48% | $105.4M | 178,299 |